Development of a novel internal control for a real-time PCR for HSV DNA types 1 and 2

https://doi.org/10.1016/j.jcv.2006.12.014Get rights and content

Abstract

Background

Detection of herpes simplex virus types 1 and 2 DNA by polymerase chain reaction (PCR) is the method of choice in many laboratories due to improved sensitivity, specificity and turnaround times compared with culture and antigen detection. However, internal controls need to be employed to ensure that inhibitors in samples do not produce false negative results.

Objective

We have developed an internal control for our routine diagnostic HSV 1 and 2 LightCycler PCR assay that has identical primer binding sites to the HSV target DNA but an internal sequence derived from plasmid DNA and detected by a different probe and fluorophore combination.

Methods

Production of the internal control was achieved using a straightforward two-step PCR technique in which plasmid DNA was amplified with HSV-plasmid chimeric primers, followed by amplification of the resulting amplicons with HSV primers and purification for subsequent use.

Results

Both the internal control and viral DNA were amplified in initial tests with 11 tissue-culture HSV 1 and 2 positives (22 in total), with little or no inhibition of the target sequences. A high level (98%) of concordant results were obtained with 272 clinical samples assayed in parallel with and without the internal control.

Conclusion

These results are sufficient to justify the incorporation of the internal control into the routine LightCycler HSV DNA assay in our laboratory.

Introduction

Improved sensitivity and specificity for detecting herpes simplex virus (HSV) DNA in genital samples by polymerase chain reaction (PCR) compared with culture and antigen detection has been demonstrated in a number of reports (Burrows et al., 2002, Stránská et al., 2004, Mengelle et al., 2004). There are also reports describing the use of internal controls to monitor the effect of inhibitors in samples, which by suppressing amplification, might result in a false negative result (Burggraf and Olgemöller, 2004, Hoorfar et al., 2004, Stöcher et al., 2004). PCR reactions are susceptible to inhibition by a variety of substances in specimens collected from patients including haemoglobin, urea, bile salts, and heparin (Wilde et al., 1990, Gerritsen et al., 1991, Akane et al., 1994, Satsangi et al., 1994). Reagents such as ethanol and SDS, used in nucleic acid extraction procedures, may also be inhibitory. Inhibition can be detected by setting up parallel reactions containing the test samples spiked with a positive control (Fout et al., 2003). However, this is laborious and increases the potential for contamination by making the test procedure more involved. An alternative method is to add an internal PCR inhibition control (IC) of non-related DNA with the test sample into the same reaction tube, this also ensures that reaction conditions for both the IC and test sample are identical (Cone et al., 1992).

One approach is to produce an IC with identical primer binding sites to the diagnostic target DNA but with internal sequences derived from plasmid DNA (Sachadyn and Kur, 1998). Using a relatively straightforward two-step PCR technique we have produced such an IC suitable for use in a routine diagnostic LightCycler real-time PCR assay to detect herpes virus types 1 and 2 DNA.

Section snippets

Construction and production of the PCR inhibition control

The 190 bp PCR IC consisted of a sequence of DNA derived from the pGEM-T Vector plasmid (Promega, Southampton, UK) flanked by the HSV forward and reverse primer binding sites (Fig. 1). This had a GC content similar to that of the HSV amplicon. The IC was produced in two rounds of amplifications using the LightCycler (Roche Diagnostics GmBH, Germany). Details of the primers and probes used for the production and detection of the IC are shown in Table 1 (all primers and probes used in this study

Results

The IC has a G + C content of 52%, identical to the HSV 1 amplicon, while the HSV 2 amplicon has a G + C content of 53%, due to A  G and T  C substitutions in the type 2 genome at base positions 2852 and 2859, respectively. Titrating the IC against a range of HSV 1and 2 tissue-culture positive controls showed that a 10−11 dilution of the purified final round PCR product was the most suitable, this equated to approximately 2 × 1010 copies μl−1. Typical melting curve peaks with melting temperatures (Tms)

Discussion

To improve our routine diagnostic service, we have developed a PCR IC for detecting inhibition in samples assayed for HSV 1 and 2 DNA by LightCycler PCR. The IC was produced by PCR amplification of plasmid DNA with HSV-plasmid chimeric primers and subsequent amplification of the resulting amplicons with HSV primers. This method has the advantage of requiring only two relatively straightforward sequential amplifications, compared with other reports (Müller et al., 1998, Rosenstraus et al., 1998,

References (21)

There are more references available in the full text version of this article.

Cited by (10)

  • Detection of nine respiratory RNA viruses using three multiplex RT-PCR assays incorporating a novel RNA internal control transcript

    2011, Journal of Virological Methods
    Citation Excerpt :

    A positive cytopathic effect (CPE) was confirmed for influenza A and B viruses, parainfluenza viruses types 1, 2 and 3, and RSV by the immunofluorescence assay described previously. The construction of the RNA internal control was based on the PCR methods reported by Tang et al. (2005) and Hodgson et al. (2007). The 188 bp amplicon for the control was produced using composite primers, incorporating the RNA internal control forward and reverse primer sequences and sequences complementary to the pGEM-T easy vector (Promega, Southampton, UK).

  • Development of a quantitative polymerase chain reaction method using a live bacterium as internal control for the detection of Listeria monocytogenes

    2008, Diagnostic Microbiology and Infectious Disease
    Citation Excerpt :

    Trace compounds from clinical samples, selective enrichment media, and nucleic acid extraction reagents can inhibit the PCR reactions and may lead to decreased amplification efficiency and inaccurate results (Al-Soud et al., 2000; Rossen et al., 1992; Wilson, 1997). To address the limitations of the Q-PCR technique, we developed an internal amplification control (IAC) (Cone et al., 1992; Hodgson et al., 2007; Liu and Shi, 2006). The IAC is coamplified with the target DNA using the same set of primers.

  • Lung function prior to viral lower respiratory tract infections in prematurely born infants

    2011, Thorax
    Citation Excerpt :

    The samples were tested using a Rotor-Gene 6000 (Qiagen) and the following conditions: (1) hold at 95°C for 15 min; and (2) 45 cycles of (a) step 1, 95°C hold for 15 s; (b) step 2, 57°C hold for 20 s, acquiring to cycle A (Cy5, ROX); and (c) step 3, 65°C hold for 20 s. The internal control was derived from a plasmid construct consisting of a 147 bp fragment of Promega's pGEM-T (Promega UK Ltd, Southampton, UK) vector with the VZV forward and reverse primer sequences incorporated into the 5′ and 3′ ends forming a chimeric molecule, amplified by the VZV primers and detected by a sequence-specific TaqMan probe (Applied Biosystems, Warrington, UK), based on the original method described previously.13 To produce the RNA internal control, the fragment was cloned back into the pGEM-T vector, reverse transcribed with Promega's Riboprobe in vitro Transcription System, as described by the manufacturer, isolated, purified and quantified using standard molecular biology techniques.

View all citing articles on Scopus
View full text